Metabolism and disposition of JNJ-10450232 (NTM-006) in rats, dogs, monkeys and humans. 2023

Heng-Keang Lim, and Jie Chen, and Wing Lam, and Yong Gong, and Laurent Leclercq, and Jose Silva, and Rhys Salter, and Joris Berwaerts, and Cathy K Gelotte, and Amy M Vakil, and Gary E Eichenbaum, and Edwin K Kuffner, and Christopher M Flores
Drug Metabolism and Pharmacokinetics, Janssen Research and Development, Spring House, PA, USA.

JNJ-10450232 (NTM-006), a novel non-opioid, non-nonsteroidal anti-inflammatory drug with structural similarities to acetaminophen, demonstrated anti-pyretic and/or analgesic activities in preclinical models and humans and reduced potential to cause hepatotoxicity in preclinical species. Metabolism and disposition of JNJ-10450232 (NTM-006) following oral administration to rats, dogs, monkeys and humans are reported. Urinary excretion was the major route of elimination based on recovery of 88.6% (rats) and 73.7% (dogs) of oral dose. The compound was extensively metabolized based on low recovery of unchanged drug in excreta from rats (11.3%) and dogs (18.4%). Clearance is driven by O-glucuronidation, amide hydrolysis, O-sulfation and methyl oxidation pathways. The combination of metabolic pathways driving clearance in human is covered in at least one preclinical species despite a few species-dependent pathways. O-Glucuronidation was the major primary metabolic pathway of JNJ-10450232 (NTM-006) in dogs, monkeys and humans, although amide hydrolysis was another major primary metabolic pathway in rats and dogs. A minor bioactivation pathway to quinone-imine is observed only in monkeys and humans. Unchanged drug was the major circulatory component in all species investigated. Except for metabolic pathways unique to the 5-methyl-1H-pyrazole-3-carboxamide moiety, metabolism and disposition of JNJ-10450232 (NTM-006) are similar to acetaminophen across species.

UI MeSH Term Description Entries

Related Publications

Heng-Keang Lim, and Jie Chen, and Wing Lam, and Yong Gong, and Laurent Leclercq, and Jose Silva, and Rhys Salter, and Joris Berwaerts, and Cathy K Gelotte, and Amy M Vakil, and Gary E Eichenbaum, and Edwin K Kuffner, and Christopher M Flores
January 2023, Regulatory toxicology and pharmacology : RTP,
Heng-Keang Lim, and Jie Chen, and Wing Lam, and Yong Gong, and Laurent Leclercq, and Jose Silva, and Rhys Salter, and Joris Berwaerts, and Cathy K Gelotte, and Amy M Vakil, and Gary E Eichenbaum, and Edwin K Kuffner, and Christopher M Flores
August 2000, Drug metabolism and disposition: the biological fate of chemicals,
Heng-Keang Lim, and Jie Chen, and Wing Lam, and Yong Gong, and Laurent Leclercq, and Jose Silva, and Rhys Salter, and Joris Berwaerts, and Cathy K Gelotte, and Amy M Vakil, and Gary E Eichenbaum, and Edwin K Kuffner, and Christopher M Flores
September 2006, Xenobiotica; the fate of foreign compounds in biological systems,
Heng-Keang Lim, and Jie Chen, and Wing Lam, and Yong Gong, and Laurent Leclercq, and Jose Silva, and Rhys Salter, and Joris Berwaerts, and Cathy K Gelotte, and Amy M Vakil, and Gary E Eichenbaum, and Edwin K Kuffner, and Christopher M Flores
January 2008, Drug metabolism and disposition: the biological fate of chemicals,
Heng-Keang Lim, and Jie Chen, and Wing Lam, and Yong Gong, and Laurent Leclercq, and Jose Silva, and Rhys Salter, and Joris Berwaerts, and Cathy K Gelotte, and Amy M Vakil, and Gary E Eichenbaum, and Edwin K Kuffner, and Christopher M Flores
August 2023, Regulatory toxicology and pharmacology : RTP,
Heng-Keang Lim, and Jie Chen, and Wing Lam, and Yong Gong, and Laurent Leclercq, and Jose Silva, and Rhys Salter, and Joris Berwaerts, and Cathy K Gelotte, and Amy M Vakil, and Gary E Eichenbaum, and Edwin K Kuffner, and Christopher M Flores
January 1992, European journal of drug metabolism and pharmacokinetics,
Heng-Keang Lim, and Jie Chen, and Wing Lam, and Yong Gong, and Laurent Leclercq, and Jose Silva, and Rhys Salter, and Joris Berwaerts, and Cathy K Gelotte, and Amy M Vakil, and Gary E Eichenbaum, and Edwin K Kuffner, and Christopher M Flores
December 2010, Drug metabolism and disposition: the biological fate of chemicals,
Heng-Keang Lim, and Jie Chen, and Wing Lam, and Yong Gong, and Laurent Leclercq, and Jose Silva, and Rhys Salter, and Joris Berwaerts, and Cathy K Gelotte, and Amy M Vakil, and Gary E Eichenbaum, and Edwin K Kuffner, and Christopher M Flores
May 2020, Xenobiotica; the fate of foreign compounds in biological systems,
Heng-Keang Lim, and Jie Chen, and Wing Lam, and Yong Gong, and Laurent Leclercq, and Jose Silva, and Rhys Salter, and Joris Berwaerts, and Cathy K Gelotte, and Amy M Vakil, and Gary E Eichenbaum, and Edwin K Kuffner, and Christopher M Flores
November 1984, Xenobiotica; the fate of foreign compounds in biological systems,
Heng-Keang Lim, and Jie Chen, and Wing Lam, and Yong Gong, and Laurent Leclercq, and Jose Silva, and Rhys Salter, and Joris Berwaerts, and Cathy K Gelotte, and Amy M Vakil, and Gary E Eichenbaum, and Edwin K Kuffner, and Christopher M Flores
August 1984, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!